Monday, March 17, 2025 | 02:44 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Maiden Pharma may lose import-export code over cough syrup deaths in Gambia

Pharmexcil suspends membership; may recommend DGFT to withdraw Import-Export Code

cough syrup, medicine, cold
Premium

File photo of cough syrup | Photo: Shutterstock

Sohini Das Mumbai
As the controversy surrounding the deaths of 66 children in Gambia being linked to India manufactured cough syrups by Delhi-based Maiden Pharmaceuticals, the Pharmaceutical Exports Promotion Council (Pharmexcil) has suspended the membership of the firm.

Going forward, the import-export code (IEC) of the company may also be withdrawn by the Directorate General of Foreign Trade (DGFT), sources said. Meanwhile, the Medicines Control Agency of Gambia has issued a notification to complete the recall of the ‘contaminated and substandard’ products of Maiden Pharma and quarantine all products of the company.

For now, the suspension of membership of Pharmexcil implies that Maiden Pharmaceuticals will

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in